Prevention of congenital Chagas through treatment of girls and women of childbearing age
AUTOR(ES)
Moscatelli, Guillermo, Moroni, Samanta, García-Bournissen, Facundo, Ballering, Griselda, Bisio, Margarita, Freilij, Héctor, Altcheh, Jaime
FONTE
Mem. Inst. Oswaldo Cruz
DATA DE PUBLICAÇÃO
15/05/2015
RESUMO
It is currently unknown whether treatment of Chagas disease decreases the risk of congenital transmission from previously treated mothers to their infants. In a cohort of women with Chagas disease previously treated with benznidazole, no congenital transmission of the disease was observed in their newborns. This finding provides support for the treatment of Chagas disease as early as possible.
Documentos Relacionados
- Evaluation of Toxoplasma, Rubella, and Cytomegalovirus serological results in women of childbearing age
- The Prevalence of Metabolic Syndrome Among US Women of Childbearing Age
- Risk factors for Toxoplasma gondii infection in women of childbearing age
- Malignant hypertension in women of childbearing age and its relation to the contraceptive pill.
- Deficiency and Insufficiency of Vitamin D in Women of Childbearing Age: A Systematic Review and Meta-analysis